TrademarkDir
IMMUNE FORMULATION
DEAD

Serial Number

97695867

Owner

The Prolmmune Company, L.L.C.

Attorney

John W. McGlynn

Filing Date

Nov 29, 2022

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

IMMUNE FORMULATION Trademark

Serial Number: 97695867

IMMUNE FORMULATION is a trademark filed by The Prolmmune Company, L.L.C. on November 29, 2022. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

The Prolmmune Company, L.L.C. (12 trademarks)

Rhinebeck, NY 12572

Entity Type: 16

Trademark Details

Filing Date

November 29, 2022

Registration Date

Not Registered

Goods & Services

Vitamins; nutritional supplements; and dietary food supplements; pharmaceutical preparations for improving immune system performance; food, dietary, and nutritional supplements for improving immune system performance

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Sep 22, 2025 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Sep 22, 2025 ABN2
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Jun 10, 2025 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Jun 10, 2025 XELR
NOTIFICATION OF FINAL REFUSAL EMAILED
Mar 10, 2025 GNFN
FINAL REFUSAL E-MAILED
Mar 10, 2025 GNFR
FINAL REFUSAL WRITTEN
Mar 10, 2025 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 10, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 10, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 10, 2025 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Nov 8, 2024 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Nov 8, 2024 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 8, 2024 GNRN
NON-FINAL ACTION E-MAILED
Aug 8, 2024 GNRT
NON-FINAL ACTION WRITTEN
Aug 8, 2024 CNRT
USE AMENDMENT ACCEPTED
Aug 4, 2024 IUAA
AMENDMENT TO USE PROCESSING COMPLETE
Jul 8, 2024 AUPC
USE AMENDMENT FILED
Jul 8, 2024 IUAF
TEAS AMENDMENT OF USE RECEIVED
Jul 8, 2024 EAAU
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 8, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 8, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 8, 2024 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Apr 8, 2024 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Apr 8, 2024 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 8, 2024 GNRN
NON-FINAL ACTION E-MAILED
Jan 8, 2024 GNRT
NON-FINAL ACTION WRITTEN
Jan 8, 2024 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 11, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 11, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 11, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 11, 2023 GNRN
NON-FINAL ACTION E-MAILED
Sep 11, 2023 GNRT
NON-FINAL ACTION WRITTEN
Sep 11, 2023 CNRT
ASSIGNED TO EXAMINER
Sep 8, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 2, 2022 NWOS
NEW APPLICATION ENTERED
Dec 2, 2022 NWAP

Related Trademarks

More from this Owner

GLUTATHIONE PROGENITOR-CORE SYNTHESIS FORMULA AND ITS RENEWABLE, INTERCONVERTIBLE ENERGY CYCLE

GLUTATHIONE PROGENITOR-CORE SYNTHESIS FORMULA AND ITS RENEWABLE, INTERCONVERTIBLE ENERGY CYCLE

GLUTATHIONE PROGENITOR-CORE SYNTHESIS FORMULA AND ITS RENEWABLE, INTERCONVERTIBLE ENERGY CYCLE

GLUTATHIONE PROGENITOR-CORE SYNTHESIS FORMULA AND ITS RENEWABLE, INTERCONVERTIBLE ENERGY CYCLE

FFAAP

FFAAP

FFAAP THE AMINO ACIDS: L-CYSTEINE GLYSINE L-GLUTAMATE SOURCE FOR PHYSIOLOGICAL SYNTHESIS OF GLUTATHIONE. logo

FFAAP THE AMINO ACIDS: L-CYSTEINE GLYSINE L-GLUTAMATE SOURCE FOR PHYSIOLOGICAL SYNTHESIS OF GLUTATHIONE.

GLUTATHIONE PROGENITOR-CORE SYNTHESIS FORMULA AND ENERGY CYCLE

GLUTATHIONE PROGENITOR-CORE SYNTHESIS FORMULA AND ENERGY CYCLE

GLUTATHIONE PROGENITOR-CORE SYNTHESIS FORMULA AND ENERGY CYCLE

GLUTATHIONE PROGENITOR-CORE SYNTHESIS FORMULA AND ENERGY CYCLE